INTRODUCTION
The airway epithelium is the first line of contact with the inhaled environment and is continually exposed to infectious or noxious agents and airborne particles that can cause acute or chronic injury. In asthma it is becoming increasingly clear that the airway epithelium responds inappropriately to challenge and displays signs of dysregulated repair, both of which may lead to airway remodeling [1, 2] . Significantly, these epithelial abnormalities can be detected prior to the onset of clinical symptoms of the disease [3] . However the mechanisms involved in epithelial repair under normal conditions are unclear and even less is known about these processes in asthma. Understanding these mechanisms of epithelial regeneration is crucial if we are to impact on the inappropriate remodeling of the airways seen in asthma.
In contrast to dermal and intestinal epithelia which are highly proliferative and rapidly renewing [4, 5] , the turnover of the airway epithelium is extremely slow unless injured [6] . Over the years, several experimental models in mice have been developed to mimic epithelial injury and repair following environmental challenges. The emerging findings from these studies demonstrate that different regions within the respiratory system: trachea and large airway, distal bronchioles and alveoli, contain different stem cells and different repair mechanisms. To date the cells reported to be enriched for stem/progenitor cell activity include: basal cells, secretory (clara) cells, or cells residing in submucosal glands [7] [8] [9] [10] . These cells may or may not reside within stem/progenitor niches such as the bronchioalveolar duct junction [11, 12] . However, information regarding lineage decisions, self renewal properties, and clonality of these cells within human airways are lacking. The difficulties of identification and isolation of these cells is associated with absence of reliable cell surface markers. Efforts to purify resident stem cells from adult tissues have focused on the Hoechst 33342 exclusion assay, which was first described by Goodell et al., [13] for hematopoietic stem cells. Side population (SP) cells are identified by flow cytometry due to a unique ability to efflux the DNA binding dye Hoechst 33342 via a cell surface multidrug resistance/ATP-binding cassette transporter protein called Breast cancer resistance protein 1 (Bcrp1/ABCG2), and have been shown to exhibit properties similar to those of hematopoietic stem cells. To date, SP cells have been isolated from several human tissues, including mammary glands [14, 15] , ocular epithelium [16] , and skin [17] . While SP cells have been identified in digests of whole murine lung tissue [18] [19] [20] , whether SP cells exist within human airway epithelium and if these cells play a role in epithelial repair still remains unknown. However, the structural complexity of the airway epithelium, relative paucity of resident stem cells and their markers, as well as sufficient tissue for cell isolation has hindered the identification of these cells in human airways.
The aim of the present study was to identify SP cells present within human tracheal and bronchial epithelium in vivo and to isolate and characterize these cells to determine their stem/progenitor cell capacity in vitro. We demonstrate that SP cells exist in human airway epithelium, express epithelial cell markers, display increased colony-forming capacity, and are able to generate a multi-layered epithelium in air-liquid interface culture. Importantly, we also demonstrate that the number of SP cells is substantially increased within asthmatic airways. Epithelial (pHBE) cells were isolated by protease digestion of human airways as previously described with minor modifications [21] . Briefly, after surgical removal specimens were washed in Custodiol® HTK (Histidine-Tryptophan-Ketoglutarate) solution and packed on ice for transportation. The trachea and bronchi to the 4 th generations were dissected and rinsed 3 times in cold PBS without Ca 2+ and Mg 2+ to completely remove blood and mucus plugs. The epithelium on intact segments of trachea and bronchi (2-4cm long) was then dissociated with 1.4 mg/ml Pronase and 0.1 mg/ml of DNase (Roche Diagnostics, Indianapolis, USA) per 100ml of MEM (Fisher Scientific, Philadelphia, USA) at 4°C for 16 hours. After digestion the tracheal/bronchial tube was rinsed with MEM and dissociated cell clumps were strained through a 70 µm nylon mesh (Becton-Dickinson, Franklin Lakes NJ). To neutralize Pronase, cells were resuspended and incubated in MEM with 10% FBS for 10 min and washed twice with MEM by centrifugation at 4°C. Approximately 20 x 10 6 cells in total were recovered from both the trachea and bronchial tissues of each individual. Adherent cells were depleted by plating cell suspension on tissue culture flasks and incubation at 37°C for 30 min. Non-adherent cells were collected, washed with MEM and resuspended at 1x10 6 cells/ml in Bronchial Epithelial Growth Medium (BEGM, Cambrex).
MATERIALS AND METHODS

Airway epithelial cell isolation
Hoechst 33342 Efflux Assay
Following time course and dose response controls based on Hoechst efflux assays, airway epithelial cells in suspension were stained with 5 ug/ml Hoechst 33342 (Sigma) alone or in combination with 50 uM Verapamil (Sigma) for 90 min at 37°C, with 5% CO 2 and intermittent mixing. Immediately after staining, cells were washed twice with ice-cold HBSS (Fisher Scientific, Philadelphia, USA) containing 0.2 mg/ml DNase and kept on ice. Staining for specific surface markers was performed at 4°C after incubation with Hoechst 33342. Briefly, cells in suspension were incubated for 30 min at 4°C with 1 μg/ml mouse anti-human CD45 (FITC-conjugated, clone 2B11, Santa Cruz Biotechnology) or isotype control (Santa Cruz Biotechnology, Santa Cruz, CA) following washing with ice-cold HBSS containing 0.2 mg/ml DNase. Propidium iodide (2 μg/ml; Sigma, ON) was added to the cell suspension 5 min before sorting to exclude non-viable cells. For all Hoechst efflux assays cell viability remained between 85-90% following the staining procedure and FACs analysis.
Flow Cytometry
Positively stained cells were sorted on a FACS DiVA (BD Biosciences), using FACS DiVA software. A UV laser and argon laser (excitation 350 and 488-nm) were used to excite the Hoechst 33342 and emissions of the dye were detected using 670/30-nm band-pass and 450/65-nm band-pass filters. SP cells were identified as described by Goodell and colleagues [22] . Detection of CD45 + SP cells was performed using a 530/40 band pass filter. Compensation was set manually using single color control. CD45 -SP cells and non-SP cells were then resorted to ensure for purity and collected directly into tissue culture plates (Costar, Corning, NY) or fixed in 4% paraformaldehyde (Fisher Scientific) for 20min for further FACs analysis. For this cells were stained with antibodies for either 1 μg/ml ABCG2/BCRP-1 (clone 5D3, StemCell Technologies, Vancouver, BC), 1 μg/ml pan-cytokeratin phycoerythin conjugated (clone C-11, abcam, Cambridge, UK), 1 μg/ml pan-p63 (clone 4A4, Santa Cruz Biotechnology, Santa Cruz, CA) or isotype controls in PBS with 0.1% saponin for 30mins at room temperature. Following washing with 0.1% saponin and 0.1% Tween20 in PBS, secondary antibody Goat antiMouse IgG Alexa Fluor 488 (Invitrogen, Oregon, USA) was used to detect ABCG2/BCRP-1 and pan-p63 before final washing. Detection of Bcrp1 and pan-cytokeratin CD45 + SP cells was performed using a 530/40 band pass filter. Compensation was set manually using single color control.
Clonogenic assay
Colony formation capacity of CD45 -SP, non-SP and unsorted cells was determined using the previously published method by Jones et al., [23] . Briefly 1, 10, 100 and 1000 cells were plated in 300µl of BEGM on to a 24-well culture plate. Clonogenic assays were carried out three times for each cell population isolated to obtain an average. Cells were allowed to adhere and propagate for 12 days and were then fixed in 4% paraformaldehyde (Fisher) for 20min, stained with Giemsa stain (Sigma, St. Louis, MO) for 30 mins, washed with water and air dried. Colonies were counted using a Zeiss Stemi 2000-C microscope (Carl Zeiss, Toronto, Canada). Colony formation was calculated as a ratio of colony numbers with >32 cells per colony to total numbers of cells plated. Colonies were also characterized by morphology; cobblestone, stellate or cells with high cytoplasmic-to-nuclear ratio. The colony forming capacity was followed over 16 passages for each cell population isolated from individual lung donor.
Immunofluorescent staining
At each passage of the clonogenic assay protocol cells were also seeded into 8 well chamber slides for characterization by immunofluorscent staining. Following 12 days in culture cells were fixed in 4% paraformaldehyde (Fisher) for 20min, stained with antibodies for either cytokeratin-5 (clone D5/16 B4, Dako), cytokeratin-18 (rabbit polyclonal, Calbiochem, Temecula, CA), ∆Np63 isoform (sc-8609), TAp63 isoform (D-20), E-cadherin (clone G-10) and vimentin (clone C-20, all Santa Cruz Biotechnology, Santa Cruz, CA) all at a concentration of 1 μg/ml in PBS with 0.1% saponin for 2 hours at room temperature. Following washing with 0.1% saponin and 0.1% Tween20 in PBS, secondary antibodies conjugated with either Goat anti-Mouse IgG Alexa Fluor 488 or Goat anti-Rabbit IgG Alexa Fluor 594 (Invitrogen, Oregon, USA) were incubated for 2 hrs at room temperature. Cells were visualized with a Nikon fluorescent microscope and imaged with a C-spot camera (Nikon Instruments, Melville, NY, USA).
Quantitative PCR to determine Telomere length Genomic DNA was extracted from CD45 -SP and non-SP cells after passage 1, 2 and 3 using QIAamp DNA mini kit (QIAGEN, Valencia, Ca). Telomere length was determined using the method previously described (Cawthorn, 2002) . PCR assays were performed on a Prism 7700 sequence detection system (Applied Biosystems, Foster City, CA).
Taqman© Gene Expression Assays
RNA was isolated from CD45
-and non-SP cells following the initial Hoechst sort and at passage using RNeasy Plus Mini-Kits (QIAGEN, Valencia, CA) as per manufacturer's instructions. Purified RNA was reverse transcribed into cDNA using TaqMan© Reverse Transcription Reagents (Applied Biosystems, Foster City, CA). E-cadherin and Vimentin gene expression was determined by real-time PCR using the Taqman© Universal PCR Master Mix (Applied Biosystems) and pre-developed Taqman© Gene Expression Assays (Applied Biosystems) as per manufacturer's instructions. Gene expression was normalized to GAPDH. Transcript expression of genes of interest were calculated with 16HBE14o-cells serving as the calibrator.
Air Liquid Interface (ALI) Culture
For ALI cultures, CD45
-and non-SP cells were seeded on 12-well polyester membrane inserts (0.4μm pore size, Costar Corning, New York) at a density of 1 x 10 2 cells per cm 2 . Cells were submerged in 0.5ml BEGM at the apical surface with 1ml added to the basal compartment and cultured at 37 o C with 5% CO 2 . Media was replaced every second day until a confluent monolayer was formed. The media was then removed from the apical compartment to bring the culture to air-liquid interface. Cells were then differentiated for a further 25-35 days in 1:1 mix of DMEM and BEBM with insulin (5.0μg/ml), transferrin (10μg/ml), hydrocortisone (0.5μg/ml), bovine pituitary extract (52μg/ml), EGF (0.5ng/ml), epinephrine (0.5ng/ml) (all Cambrex), 0.1μΜ All-trans retinoic acid, 100u/ml penicillin, and 100μg/ml streptomycin (all SIGMA). The medium was replaced every 2 days, and cultures were incubated at 37˚C in humidified air with 5% CO 2 . Membranes were processed for histological and immunohistochemical analysis following 25 days in culture. All independent experiments were preformed in triplicate.
Immunohistochemical Staining of ALI Sections
Sections were de-paraffinized and rehydrated, and subject to antigen retrieval by autoclaving (15mins, 120˚C, 30psi) for 20 min in citrate target retrieval solution (Dako, Mississauga, ON). Subsequently, endogenous peroxidase was quenched with 3% H 2 O 2 and blocked for 20min with 50% goat serum. Primary mouse anti human cytokeratin-5 (1μg/ml clone D5/16 B4, Dako), cytokeratin-18 (1μg/ml rabbit polyclonal, Calbiochem, Temecula, CA), or p63 (1μg/ml clone 4A4, Santa Cruz Biotechnology, Santa Cruz, CA) were added overnight at 4°C in 25% goat serum. Sections were then incubated with a biotinylated goat anti-mouse secondary antibody (1:100, Vector Labs Burlingame, CA) for 60 min followed by a 10 min treatment with Streptavidin-HRP (Dako, Mississauga, ON). The antigen of interest was visualized by using the brown chromogen 3,3-diaminobenzidine (Dako, Mississauga, ON) and counterstained with Harris Hematoxylin Solution (Sigma, Oakville, ON). Sections were then dehydrated and mounted with Cytoseal 60 (Richard-Allan Scientific, Kalamazoo, MI). Antibody dilutions and all washes were in TRIS-buffered saline solution.
Statistical Analysis
The mean percentages of CD45 -SP cells, clonogenic capacity and mean telomere length were compared using an unpaired Student's t test. A p value < 0.05 was considered to be statistically significant.
RESULTS
Cells with an SP phenotype exist within human tracheal and bronchial epithelium
Human tracheal and bronchial epithelial cells were obtained via pronase digestion of airway tissue from five normal adults, patient demographics are presented in Table 1 . On average 5 x10 6 epithelial cells were obtained from the trachea and 15 x 10 6 cells from the bronchial tissue as shown by the forward and side scatter plots ( Figure 1A and E). SP cells were then immediately isolated from both tracheal and bronchial preparations by flow cytometry and cell sorting based on Hoechst 33342 exclusion. In each experiment, cell viability remained 85 -90% following Hoechst 33342 and verapamil treatment as shown by the histogram plots for propidium iodide staining ( Figure 1B and F) . Density dot plot analysis confirmed the presence of a defined SP profile in both tracheal and bronchial cell preparations ( fig  1C and G, region R1) . The average percentage of SP cells isolated from normal donors was 0.12 ±0.01%, irrespective of anatomical localization (n=7). The specificity of Hoechst efflux by Bcrp1 was confirmed by incubation of cells with the calcium channel inhibitor Verapamil ( figure  1D and H, region R1). As we observed no difference in the percentage of SP cells obtained from either the trachea or bronchus, cells were pooled for further experiments.
All SP cells stained positive for surface expression of Bcrp1 and pan-cytokeratin, which is found only in the intra-cytoplasmic cytoskeleton of epithelial tissue as shown in figures 1I and J compared to the isotype controls. Airway SP cells were also sorted for the presence of the hematopoetic stem cell marker CD45. The SP population was heterogenous for CD45 expression, containing on average 7% CD45 positive (CD45 + ) ( Figure 1K ). Only CD45 negative (CD45 -) SP cells were collected for further analysis, as our study was focused on epithelial resident SP cells and CD45 + SP represented a minute fraction of the total SP population. -SP cells seeded at any cell density, were able to form colonies, which were all cobble stone in appearance (Figure 2A) . In contrast only 20±0.2% of non-SP cells and 22±1.2% of un-sorted cells seeded at 1000 cells/well were able to form colonies >32 cells, but these were stellate in appearance and failed to divide further (figure 2B).
Immunofluorescent staining of CD45
-SP cells at initial passage demonstrated expression of epithelial basal cell markers; transcription factor ΔNp63, cytokeratin-5, CD151 and tissue factor ( Figure 2C , D, E and F respectively), epithelial adherens junction protein E-cadherin and tight junctional protein ZO-1 (figures 2G and H), but were negative for the mesenchymal marker vimentin (data not shown) indicating all cells were of epithelial phenotype. However, we also found no evidence for cytokeratin-18 or Muc5AC expression (data not shown). Following passage, 5% of cells retain Bcrp-1 positivity on the cell membrane in a pattern that may represent channels. In the remaining cells that stained positive for Bcrp-1, the immunofluorescence exhibited a distinct perinuclear staining pattern ( Figure 2I ). The expression of E-cadherin (grey bars) and lack of mesenchymal marker vimentin (black bars) were also confirmed by quantitative RT-PCR ( figure  2J ). Furthermore CD45 -SP cells were able to maintain their colony forming capacity over 5 passages (figure 2K), in contrast non-SP cells which were capable of limited propagation over 3-4 passages when seeded at 20,000 cells per well (data not shown).
Telomere length is maintained in SP cells over consequent passages Multiple cell divisions in differentiated cells results in telomere shortening and dysfunction, which leads to DNA damage responses and ultimately irreversible cellular senescence [24, 25] . We analyzed telomere length in CD45 -SP and non-SP cells over sequential passages. As shown in figure 3 mean telomere length normalized to control in CD45 -SP cells remained constant (0.997±0.02) over three passages compared to non-SP cells in which the mean telomere length shortened to 0.62± 0.04 by passage 3 (P<0.05).
SP cells seeded at low densities are capable of generating a differentiated epithelium in air liquid interface cultures
As CD45 -SP cells show substantial colony formation capacity in monolayer culture, it was important to determine if these cells could produce a multi-layered differentiated epithelium. CD45
-SP cells were capable of differentiating into a multilayered epithelium consisting of basal cells which stained positive for the epithelium restricted transcription factor, ΔNp63, which is important in epithelial proliferation and differentiation and CK-5 as well as ciliated cells characterized by positive staining for CK-18 (figures 4 A, B and C respectively) We also observed positive staining for the muc5AC (figure 4D), as well as the basal cell markers Tissue Factor (figure 4E) and CD151 ( figure 4F ). The localization of ΔNp63, CK-5 and CK-18 observed within the ALI cultures was comparable to that seen in histological sections of the same donor airways that were embedded prior to epithelial cell isolation (figures 4 G-L).
Asthmatic epithelium has elevated numbers of airway SP cells
In both pediatric and adult airways from normal donors, SP cells represented 0.12 ±0.01% of the cell population ( Figure 5B, region R1 ). In contrast, we observed a 40-fold increase in the number of SP cells within the asthmatic airways ( Figure 5E , region R1). Although the asthmatic airways had a greater number of SP cells Hoechst efflux was still inhibited by incubation with Verapamil ( Figures 5C and F) the percentage of SP cells were plotted by disease for each patient the mean number of SP cells within the asthmatic airway epithelium was 4.0 ±0.08%, (n=4) compared to the normal airways mean 0.12 ±0.01%, (n=7) (figure 5G). Despite the substantial increase in overall SP number observed in asthmatic airways, the proportion of CD45 + SP cells remained at approximately 7% (data not shown). Expression of the epithelial markers demonstrated in figure  2 were also found to be expressed in asthmatic CD45 -SP cell colonies and representative images for ΔNp63 and E-cadherin are shown in figure  5H and I. Additionally the mean colony forming capability of CD45 -SP cells was 63.7±1.2% which was not significantly different to CD45 -SP cell from non-asthmatics.
DISCUSSION
The results of this study demonstrate for the first time the existence of resident SP cells within human airway epithelium. We report that SP cells in normal airways represent approximately 0.1% of the total epithelial cell population. We found that 93% of the SP population were CD45 -, had sustained colony forming capacity, maintained telomere length over serial passage and importantly were able to form a differentiated, multi-layered epithelium, confirming their stem cell capacity. In addition we report that asthmatic airway epithelium contains 40-fold more SP cells compared to normal airways. However, despite the increase in SP numbers, functional differences between SP isolated from asthmatics and non-asthmatic subjects were not observed.
The epithelium is constantly exposed to a vast array of environmental stimuli including airborne allergens, pathogens and potential toxic agents and as such, must respond effectively to cellular damage and the resultant inflammatory cytokine response, in order to restore adequate barrier function. One approach to further our understanding of the repair process is to characterize the resident stem/progenitor cells that contribute to epithelial repair. We isolated epithelial cells from human trachea and 4 th generation bronchi and found that the number of SP cells, characterized by verapamil-sensitive efflux of Hoescht 33342 and Bcrp1 expression represents less than 0.12% of the total population, irrespective of anatomical localization. That SP cells represent a small fraction of epithelial cells is consistent with data from other organs including breast, lung and skeletal [14, 20, 26] . In addition to bcrp-1, several other ABC transporter proteins have been identified on SP cells. For example, Loebinger et al., recently showed that carcinomas express ABCG2(BCRP1) and ABCC1 (MRP1) transporters by quantitative PCR [27] . However, Summer et al., showed previous studies in Bcrp-1 null mice do not have lung SP cells [18] and Scharenberg et al., compared mRNA levels for MDR1, MRP1, and Bcrp-1 in bone marrow SP cells and showed that Bcrp-1 is the predominant form in these cells [28] . For these reasons, we focused on Bcrp-1 in this study.
SP cells were further sorted into hematopoeitic and nonhematopoetic lineage according to CD45 expression, which is uniformly expressed on bone marrow SP cells. We found that the overwhelming majority (93%) of SP cells were CD45 -. These data are in keeping with studies in murine tissues such as muscle [26] , kidney [29] and lung [19] where 84-96% of the SP population are CD45 -, while in tissues such as heart [30, 31] , testis [32] [18] reported that up to 60-70% of SP cells within mouse lung were CD45 + . The reasons underlying this discrepancy are unclear, but likely relate to cell extraction and sampling methodology and the use of whole minced and enzyme digested lung versus isolation from a specific tissue compartment. It has been proposed that in skeletal muscle at least, that CD45 + SP cells represent a circulating, transiently resident hematopoietic stem cell population distinct from tissue specific SP, since only CD45 + SP cells were capable of hematopoietic differentiation [26] . As epithelial -and this population represents over 90% of the airway epithelial SP we focused our attention on these cells.
CD45
-SP cells were found to be highly clonogenic in colony formation assays over both short and long term passage. Importantly a single CD45 -SP cell was able to form colonies of >32 cells following 12 days in culture without the addition of extracellular matrix or a feeder layer of cells. However, non-SP cells were only able to form viable epithelial colonies when seeded at densities >5000 cells/cm 2 . These findings are consistent with previous studies in murine lungs and skin which reported lung SP cells to have high clonogenic potential in xenografts and in vitro cell culture [18, 20] . Both tracheal and bronchial CD45
-SP cells formed cobblestone colonies characteristic of cultured epithelial cells. An epithelial phenotype of CD45 -SP cells was further confirmed by positive immunohistochemical staining for the epithelial markers pan-cytokeratin, ZO-1 and E-cadherin. However, these cells did not stain for the mesenchymal marker vimentin or express vimentin mRNA. In contrast, studies using murine SP cells isolated from both trachea and lung have reported vimentin expression and a stellate appearance of tracheal SP cells [20] . These contrasting findings could be due to differences in culturing conditions. Reynolds and colleagues [20] used FBS in their media for both tracheal (10%) and lung (2%) SP cell cultures, whereas in our study, serum free media was used to propagate SP cultures.
On further investigation, CD45
-SP colonies expressed the epithelial restricted protein CK-5 and the transcription factor p63. Previous studies using human epithelium have demonstrated that CK-5 expressing epithelial cells have progenitor properties [9, 34] . p63, which has been previously demonstrated to play a critical role in the normal morphogenesis and differentiation of the tracheobronchial epithelia, is thought to be important for the differentiation of early stem cells into the basal cell population. Indeed studies in murine mammary glands [35] , rat limbal [36] , and rabbit limbocorneal [37] cells have shown p63 to be expressed in SP cells. p63 belongs to the p53 family of transcription factors and the gene encodes for two major isoforms, TAp63 which is transcribed from the 5'-promoter; and ΔNp63, which lacks the Nterminal transcription-activating domain, and is transcribed from the intronic internal promoter. Each isoform has been shown to have separate functions and form complicated networks in different systems [38, 39] . We observed the most abundant isoform expressed in CD45 -SP cells was ΔNp63, which is in keeping with other epithelial tissues [40] and we did not observe expression of the TA isoform. It is temping to conclude that p63 is important in maintaining the resident airway CD45
-SP epithelial population. Attempts at staining airway sections to investigate SP cell localization did not allow specific discrimination of SP cells since CK-5 + /p63 + cells are expressed throughout the entire basal airway epithelial compartment and this represents approximately 25% of the total airway epithelium. Similarly, Bcrp-1 expression is not confined to SP cells. Further work is required to determine to the relationship between p63 and stem cell function in SP cells, and to characterize specific markers which could be used to determine the exact anatomical localization of resident SP cells within the airways.
The lineage commitment decisions of SP cells have obvious implications for the composition of the airway epithelium and it is presently unclear whether human SP cells function as progenitors for glandular and/or airway epithelium. To begin to address this, we have determined the capacity of SP cells to form a multi-layered differentiated epithelium in ALI culture. We show that <100 CD45 -SP cells were able to proliferate and differentiate into a multi-layer differentiated ALI culture, containing both basal, ciliated cells and mucus secreting cells. In contrast, as many as 5 x 10 5 non-SP cells were required to form a differentiated epithelium in culture. Several previous studies have shown that transiently amplifying (TA) cells or putative progenitor In the stem cell compartment of several tissues, heightened telomerase activity has been demonstrated [43] . In particular telomerase activity has been shown to be concentrated in epithelial cells near the basal lamina during human fetal lung gestation [44] , as well as in human adult bronchial basal cells [45] . We found that airway epithelial CD45 -SP cells were able to maintain telomere length over passage compared to non-SP cells. This finding is consistent with studies investigating mesenchymal stem cells aging in vitro [46] . Given that telomerase activity is detected in the basal cells of adult nasal epithelium which retain transit-amplifying cell properties [41] , our data provides further evidence that SP cells are enriched for progenitor activity.
Studies focused on the airway epithelium in asthma have previously reported markers of damage and dysregulated repair even in the early stages of the disease in childhood. As such, it was of importance to determine if SP cell number or function were altered in asthmatic airways. To begin to address these questions we obtained the lungs of four asthmatics. Our findings show that asthmatic airways contained 40-fold more CD45 -SP cells than normal airways. The increase in SP cells within the asthmatic airways did not appear to be an agerelated factor since non-diseased pediatric airways had the same frequency of SP cells when compared to normal adults. However, despite the substantial increase in numbers, we were unable to detect any differences in the function of SP cells isolated from asthmatic airways. Until recently airway remodeling in the development of asthma was considered a secondary phenomenon due to persistent inflammation. However, the importance of tissue remodeling especially within the epithelium has now been convincingly shown to be an early and consistent component of childhood asthma [3] .
As this was a prospective study we were unable to address the underlying cause for the increased numbers of CD45 -SP cells in asthmatic epithelium. However, it is an important clinical finding which supports the hypothesis that early pathological changes related to disturbances in the local epithelial environment due to stress and or injury occur within the airways of asthmatics. As such, further understanding of epithelialresident progenitor cells involved in normal regeneration as well as disease is essential and is the focus of long term future studies.
In conclusion, we demonstrate for the first time the presence of resident CD45 -SP cells within the human tracheobronchial epithelium. CD45 -SP cells exhibited epithelial cell markers cytokeratin-5, E-cadherin, ZO-1 and p63. These cells show robust colony forming and clonogenic capacity and well maintained telomere length, all of which are indicative of stem/progenitor cell function. Importantly, these cells give rise to a multi-layered differentiated epithelium in ALI culture. Our preliminary data suggest that SP cells are over expressed in asthmatic epithelium, which may indicate an abnormality in the wound repair process that could contribute to the pathogenesis of the disease. Further work is required to determine the role of resident SP cells in epithelial repair in vivo and how this may be altered by disease. Figure 1 . Identification of SP cells in human airways. Isolated airway epithelial cells from the trachea and bronchus as shown by forward and side scatter plots (A and E) were 90% viable by propidium iodide staining (B and F). Cells from both the trachea and bronchus were stained with 5μg/ml Hoechst 33342 alone (C and G respectively) or in combination with 50μg/ml verapamil (D and H). Results indicate that a SP cells exist in both the trachea (C, region R1) and bronchus (G, region R1) and represent 0.12% ±0.01 of the epithelial population (n=7). Detection of SP cells was inhibited by the calcium channel blocker verapamil (D and H, gate R1). The data shown is representative of all the normal airways analyzed in this study. Following incubation with Hoechst 33342, cells were stained and analysed by FACs for Bcrp-1 and pan-cytokeratin to confirm epithelial SP phenotype (I and J). Airway SP cells were further segregated using FACs by positive staining for CD45, 93% of airway SP cells were CD45 -compared to 7% which were CD45 + (K). 
